Jane Street’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.69M | Buy |
997,510
+390,292
| +64% | +$1.98M | 0.01% | 3621 |
|
|
2025
Q4 | $2.59M | Buy |
607,218
+205,851
| +51% | +$782K | ﹤0.01% | 4328 |
|
|
2025
Q3 | $1.28M | Buy |
401,367
+389,399
| +3,254% | +$877K | ﹤0.01% | 5799 |
|
|
2025
Q2 | $27.2K | Sell |
11,968
-7,994
| -40% | -$12.9K | ﹤0.01% | 9308 |
|
|
2025
Q1 | $12.7K | Sell |
19,962
-1,691
| -8% | -$1.31K | ﹤0.01% | 9180 |
|
|
2024
Q4 | $22.3K | Sell |
21,653
-5,578
| -20% | -$6K | ﹤0.01% | 9118 |
|
|
2024
Q3 | $32.1K | Sell |
27,231
-52,470
| -66% | -$66.6K | ﹤0.01% | 9237 |
|
|
2024
Q2 | $97.2K | Sell |
79,701
-104,047
| -57% | -$207K | ﹤0.01% | 8734 |
|
|
2024
Q1 | $401K | Buy |
183,748
+154,509
| +528% | +$285K | ﹤0.01% | 7085 |
|
|
2023
Q4 | $45.3K | Buy |
+29,239
| New | +$38.4K | ﹤0.01% | 8795 |
|
|
2023
Q3 | – | Sell |
-19,364
| Closed | -$33.3K | – | 8737 |
|
|
2023
Q2 | $33.3K | Sell |
19,364
-21,217
| -52% | -$35.2K | ﹤0.01% | 8289 |
|
|
2023
Q1 | $61.3K | Sell |
40,581
-978
| -2% | -$2.21K | ﹤0.01% | 8400 |
|
|
2022
Q4 | $66.5K | Buy |
+41,559
| New | +$61.5K | ﹤0.01% | 8266 |
|
|
2022
Q2 | – | Sell |
-20,061
| Closed | -$54K | – | 9809 |
|
|
2022
Q1 | $54K | Buy |
20,061
+1,241
| +7% | +$4.76K | ﹤0.01% | 9665 |
|
|
2021
Q4 | $81K | Buy |
+18,820
| New | +$110K | ﹤0.01% | 9329 |
|
|
2021
Q3 | – | Sell |
-84,724
| Closed | -$536K | – | 10044 |
|
|
2021
Q2 | $536K | Buy |
84,724
+67,330
| +387% | +$524K | ﹤0.01% | 7096 |
|
|
2021
Q1 | $134K | Buy |
17,394
+2,045
| +13% | +$16.2K | ﹤0.01% | 8511 |
|
|
2020
Q4 | $101K | Sell |
15,349
-3,811
| -20% | -$27.2K | ﹤0.01% | 7197 |
|
|
2020
Q3 | $127K | Buy |
19,160
+3,121
| +19% | +$23.1K | ﹤0.01% | 6671 |
|
|
2020
Q2 | $134K | Buy |
+16,039
| New | +$149K | ﹤0.01% | 6593 |
|
Other funds holding CTMX
KCM
PA
VA
VCM
